Pharmaniaga

Pharmaniaga is a leading pharmaceutical company based in Malaysia. It is involved in the manufacturing, marketing, and distribution of both generic and patented drugs. Pharmaniaga is a subsidiary of Boustead Holdings Berhad, a diversified conglomerate in Malaysia.

History[edit | edit source]

Pharmaniaga was established in 1994 as a result of a strategic merger between UPA Corporation and Pharmaceutical Services. The company was listed on the Main Board of the Kuala Lumpur Stock Exchange in 1999.

Operations[edit | edit source]

Pharmaniaga operates in two main segments: logistics and distribution, and manufacturing. The logistics and distribution segment provides warehousing, distribution, and other value-added services to the healthcare sector. The manufacturing segment produces a wide range of generic pharmaceuticals in various dosage forms, including tablets, capsules, syrup, cream, ointment, and injectables.

Products[edit | edit source]

Pharmaniaga's product portfolio includes over 500 products in various therapeutic areas, such as cardiovascular, diabetes, gastrointestinal, respiratory, and women's health. The company also manufactures over-the-counter (OTC) products and health supplements.

Research and Development[edit | edit source]

Pharmaniaga's Research and Development (R&D) department is committed to developing new and improved pharmaceutical products. The company's R&D efforts are focused on improving existing products and developing new formulations to meet the evolving needs of the healthcare industry.

Corporate Social Responsibility[edit | edit source]

Pharmaniaga is committed to corporate social responsibility (CSR) initiatives that contribute to the well-being of the communities in which it operates. The company's CSR activities include health awareness campaigns, educational programs, and community outreach programs.